Search

everythinglearnresearchcommunity

for

Search:↓

More precise, personalized therapies are needed for autoimmune diseases.

Chitosan is a sustainable, versatile ingredient in cosmetics, enhancing skin hydration and anti-aging while promoting eco-friendly practices.

Alopecia areata is an incurable autoimmune condition causing hair loss, with research aiming for better treatments.

Current treatments for Alopecia Areata have mixed success, and there's a need for better, more accessible options and support for affected individuals.

Alopecia Areata affects young adults more in high-income countries, especially females.

The guideline emphasizes a multidisciplinary approach and informed consent for gender-affirming hormone treatment, with regular follow-ups and individualized care.

Mesotherapy can be beneficial but has risks if misused.

The JAK/STAT pathway is important in cell processes and disease, and JAK inhibitors are promising for treating related conditions.

Nanocarriers can improve drug delivery through the skin by overcoming barriers.

JAK inhibitors show promise for treating skin conditions like eczema, hair loss, and psoriasis.

Chitosan, a natural substance, can be used to create tiny particles that effectively deliver various types of drugs, but more work is needed to improve stability and control of drug release.

Secondary syphilis in Cali, Colombia, shows high Treponema pallidum presence and challenges in early diagnosis, needing better public health strategies.

Microneedle technology has advanced for painless drug delivery and sensitive detection but faces a gap between experimental use and clinical needs.

MDSC-Exo can treat autoimmune alopecia areata and promote hair regrowth in mice.

Ethosomes enhance skin penetration better than liposomes, benefiting therapeutic and cosmetic applications.

Improving CRISPR/Cas systems can make gene editing more efficient and precise.

African Americans faced worse COVID-19 outcomes due to a mix of social, environmental, and biological factors.

Bubble-based systems show promise for precise, targeted drug delivery and diagnosis, especially in cancer treatment.

Tailored treatments for alopecia areata are recommended based on severity and patient needs.

Men face more severe COVID-19 outcomes, while women are more likely to have long-term symptoms.

Proxalutamide improved recovery, lowered death rates, and reduced hospital stay for COVID-19 patients.

Men are more at risk for severe COVID-19 due to biological differences, suggesting the need for targeted treatments.

Bioengineered microneedles and nanomedicine offer promising, precise treatments for tissue regeneration.

Oral lichen planus is a chronic disease causing mouth discomfort and sometimes needs immunosuppressive treatment.

The guidelines standardize mesotherapy practices for safety and effectiveness in pain, rehabilitation, and skin treatments.

Our microbiome may affect the development of the hair loss condition Alopecia Areata, but more research is needed to understand this relationship.

Biologic therapies can cause various adverse events, but allergy/immunology clinicians can manage them.

New CRISPR/Cas9 variants and nanotechnology-based delivery methods are improving cancer treatment, but choosing the best variant and overcoming certain limitations remain challenges.

JAK inhibitors show promise for treating various skin disorders effectively and safely.

Hair specialists vary in testing for alopecia areata, highlighting the need for standard guidelines.